RxDoctor Payments Data

Bahaa Malaeb, MD

Urology · Ann Arbor, MINPI 1043474919

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $63,288 of the $97,628 with a category attached, or 64.8%. Boston Scientific accounts for 86.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $54,299 and has fallen 97.5% since, to $1,352 in 2025. Among urology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$97,628in general payments, 2019–2025

Across 106 payments — averaging $921.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$84K
  • Coloplast$13K
  • Axonics, Inc.$91
$53,770in research payments, 2019–2025

Across 13 payments — averaging $4136.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Uromedica, Incorporated$54K

What the payments were for

  • Consulting fees$1,5902%
  • Speaking & faculty fees$63,28865%
  • Travel & lodging$19,15420%
  • Food & beverage$4,2214%
  • Education$9,37510%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific87$84,395
Coloplast18$13,142
Axonics, Inc.1$91

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,628 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan

Medicare billing

Part B allowed, 2024
$64,401
Medicare patients
165
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron15$17,313
Solifenacin Succinate15$991
Tamsulosin Hcl33$497
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$365
Cephalexin42$352
Oxybutynin Chloride ErOxybutynin Chloride12$340
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$159
Oxybutynin Chloride11$152
Ciprofloxacin Hcl11$65
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$43
Oxycodone Hcl13$38

Paid to pharmacies, not to this prescriber.

Other urology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →